Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Xconomy: Oncoresponse Nabs $40M For Cancer Drugs Based On Survivors’ Antibodies
LPNEWS

Xconomy: Oncoresponse Nabs $40M For Cancer Drugs Based On Survivors’ Antibodies

by xconomy.com posted 1week ago 17 views
Houston—OncoResponse, a Seattle biotech startup formed jointly with the University of Texas M.D. Anderson Cancer Center in Houston, announced Tuesday it has raised a $40 million Series B round of funding. RiverVest Venture Partners led the round, which included new investors Redmile Group and the Qatar Investment Authority, as well as existing investors Alexandria Venture […]

In this article